Kazia Therapeutics Limited American Depositary Shares (KZIA) Stock Price, Quote & AI Analysis
Live KZIA stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Kazia Therapeutics Limited American Depositary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Kazia Therapeutics Limited American Depositary Shares (KZIA), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Kazia Therapeutics Limited American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Kazia Therapeutics Limited American Depositary Shares Overview
Company information
Company Overview
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Kazia Therapeutics Limited American Depositary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...